INSIGHTS ON DRUG DEVELOPMENT

• Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

  Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

• Integration From Formulation Development To Manufacturing, Packaging

  Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

• Analyzing Biological Drug Effects In 3D

  Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.

• Modifying The Micro-Environment To Improve Dissolution Rate

  Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

• The Importance Of Recording Zero In The Digital Age

  4/9/2024

  Explore the value of negative results and how proper data management enables your digital maturity journey towards scientific advancement.

• Thunderstruck By Antibody-Drug Conjugates

  3/18/2025

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• Advancing Cell Therapies With Lipid Nanoparticles

  3/24/2025

  Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.

• The Future Of Preclinical Animal Models In Drug Discovery

  5/10/2024

  The paradigm shift from animal to human Organ-Chips in preclinical research offers promising insights and efficiencies, crucial for advancing drug development and reducing human suffering.

• Modeling Virus Evolution, Rapid Drug Repurposing With Human Airway Lung-Chips

  8/2/2024

  In this presentation, we introduce the human Airway Lung-Chip, which can model influenza virus infection and evolution in vitro and evaluate therapeutics for both influenza and SARS-CoV-2.